From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets
Clinical trials sponsored by From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Bergamo hospitals launch hunt for hidden hepatitis delta cases Results expected Sep 2026 (estimated)
- New drug for rare blood cancer studied in everyday practice Results expected Sep 2026 (estimated)
- Blood disorder evolution: researchers track hidden transformation Results expected Dec 2026 (estimated)
- Hidden blood mutations linked to heart failure? Results expected Aug 2027 (estimated)
-
Blood cancer drug shows promise in Long-Term study
Disease control CompletedThis study follows 36 Italian patients with Polycythemia Vera who responded well to Ropeginterferon alfa-2b in an earlier trial. Researchers will check every 6 months whether the treatment continues to keep their red blood cell levels normal and prevent the disease from getting w…
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Heart failure study aims to predict and prevent hospital readmissions
Knowledge-focused CompletedThis study looked at data from over 2,400 people with heart failure to find better ways to predict who is at risk for serious events like death or hospital stays. Researchers tested a care model that uses risk scores to guide treatment. The goal was to improve survival and reduce…
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New registry aims to shed light on angelman syndrome
Knowledge-focused CompletedThis completed registry study collected information from 82 people with Angelman syndrome in Italy. The goal was to track medical and behavioral problems linked to the condition. No treatments or interventions were tested; instead, the data will help researchers better understand…
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
COVID-19 blood clot risk in MPN patients under microscope
Knowledge-focused CompletedThis completed study looked at 552 adults with myeloproliferative neoplasms (MPN) who also had COVID-19. Researchers wanted to see how often these patients developed blood clots, like pulmonary embolism. The goal was to understand what factors make COVID-19 worse for people with …
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:17 UTC